We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Boston Scientific, Guidant Transaction to Be Delayed
Boston Scientific, Guidant Transaction to Be Delayed
April 7, 2006
Boston Scientific stock rose April 6 after the devicemaker won antitrust clearance from the Federal Trade Commission (FTC) for its $27 billion acquisition of former rival Guidant, whose shares also rose, according to published reports.